{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:33:00Z","timestamp":1768433580427,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Currents in Pharmacy Teaching and Learning"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.cptl.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T07:09:11Z","timestamp":1542870551000},"page":"166-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Opioid overdose response training in pharmacy education: An analysis of students\u2019 perception of naloxone use for opioid overdose prevention"],"prefix":"10.1016","volume":"11","author":[{"given":"Amy","family":"Bachyrycz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko Y.","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Wittstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Bleske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cptl.2018.11.007_bib0001","doi-asserted-by":"crossref","unstructured":"Rudd R, Seth P, David F, et al. Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015. Morbidity and Mortality Weekly Report (MMWR). Centers for Disease Control and Prevention. Published December 2016. https:\/\/www.cdc.gov\/mmwr\/volumes\/65\/wr\/mm655051e1.htm. Accessed 6 November 2018.","DOI":"10.15585\/mmwr.mm655051e1"},{"key":"10.1016\/j.cptl.2018.11.007_bib0002","unstructured":"2015 National Drug Threat Assessment Summary. Drug Enforcement Administration. https:\/\/www.dea.gov\/sites\/default\/files\/2018-07\/2015%20NDTA%20Report.pdf. Accessed 6 November 2018."},{"key":"10.1016\/j.cptl.2018.11.007_bib0003","unstructured":"Overview of Opioid Risk. Opioid Safety 2011. New Mexico Department of Health. http:\/\/nmhealth.org\/publication\/view\/general\/275\/. Accessed 6 November 2018."},{"issue":"7","key":"10.1016\/j.cptl.2018.11.007_bib0004","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1517\/14740338.2015.1037274","article-title":"Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review","volume":"14","author":"Kim","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"10.1016\/j.cptl.2018.11.007_bib0005","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.addbeh.2005.07.020","article-title":"Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City","volume":"31","author":"Galea","year":"2006","journal-title":"Addict Behav"},{"issue":"Suppl 2","key":"10.1016\/j.cptl.2018.11.007_bib0006","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1111\/j.1526-4637.2011.01128.x","article-title":"Project Lazarus: community-based overdose prevention in rural North Carolina","volume":"12","author":"Albert","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.cptl.2018.11.007_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.cptl.2018.11.007_bib0008","unstructured":"Adams J. Surgeon general's advisory on naloxone and opioid overdose. US Departmet of Health and Human Services. https:\/\/www.surgeongeneral.gov\/priorities\/opioid-overdose-prevention\/naloxone-advisory.html. Accessed 6 November 2018."},{"issue":"1","key":"10.1016\/j.cptl.2018.11.007_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cptl.2018.11.007_bib0010","series-title":"SAMHSA Opioid Overdose Prevention Toolkit","article-title":"SAMHSA Opioid Overdose Prevention Toolkit","year":"2013"},{"key":"10.1016\/j.cptl.2018.11.007_bib0011","unstructured":"Nikirk MG, Fink III JL. Legal issues with naloxone availability conferring authority and insulating from liability. Pharmacy Times. Published May 2017. http:\/\/www.pharmacytimes.com\/publications\/issue\/2017\/may2017\/legal-issues-with-naloxone-availability-conferring-authority-and-insulating-from-liability. Accessed 6 November 2018."},{"key":"10.1016\/j.cptl.2018.11.007_bib0012","unstructured":"Naloxone Access in Community Pharmacies. National Alliance of State Pharmacy Associations. Published April 2018. https:\/\/naspa.us\/resource\/naloxone-access-community-pharmacies\/. Accessed 6 November 2018."},{"issue":"4","key":"10.1016\/j.cptl.2018.11.007_bib0013","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/08897077.2016.1179704","article-title":"Co-prescription of naloxone as a universal precautions model for patients on chronic opioid therapy-observational study","volume":"37","author":"Takeda","year":"2016","journal-title":"Subst Abus"},{"key":"10.1016\/j.cptl.2018.11.007_bib0014","article-title":"Reviewing state-mandated training requirements for naloxone-dispensing pharmacists [published online ahead of print 5 April 2018]","author":"Roberts","year":"2018","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.cptl.2018.11.007_bib0015","unstructured":"Krasnow B. New Mexico pharmacists to prescribe anti-overdose drug. Santa Fe New Mexican. Published March 2014. http:\/\/www.santafenewmexican.com\/news\/health_and_science\/new-mexico-pharmacists-to-prescribe-anti-overdose-drug\/article_1399d567-d665-5017-b20a-9ff071dde447.html. Accessed 6 November 2018."},{"key":"10.1016\/j.cptl.2018.11.007_bib0016","unstructured":"Pharmacy: Requirements and Continuing Education. New Mexico Regulation & Licensing Department. http:\/\/www.rld.state.nm.us\/boards\/Pharmacy_Requirements_and_Continuing_Education.aspx. Accessed 6 November 2018."},{"issue":"1","key":"10.1016\/j.cptl.2018.11.007_bib0017","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08897077.2016.1184739","article-title":"Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery","volume":"38","author":"Bachyrycz","year":"2017","journal-title":"Subst Abus"},{"key":"10.1016\/j.cptl.2018.11.007_bib0018","article-title":"Barriers and facilitators to dispensing of intranasal naloxone by pharmacists [published online ahead of print 5 December 2017]","author":"Bakhireva","year":"2017","journal-title":"Subst Abus"},{"key":"10.1016\/j.cptl.2018.11.007_bib0019","series-title":"New Mexico State Board of Pharmacy","first-page":"1","article-title":"New Mexico Statewide Standing Order for Naloxone","author":"Landen","year":"2014"},{"key":"10.1016\/j.cptl.2018.11.007_bib0020","series-title":"New Mexico State Board of Pharmacy","first-page":"1","article-title":"Protocol for pharmacist prescribing on naloxone rescue kit","year":"2014"},{"issue":"1","key":"10.1016\/j.cptl.2018.11.007_bib0021","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cptl.2017.09.007","article-title":"A naloxone and harm reduction educational program across four years of a doctor of pharmacy program","volume":"10","author":"Maguire","year":"2018","journal-title":"Curr Pharm Teach Learn"},{"key":"10.1016\/j.cptl.2018.11.007_bib0022","doi-asserted-by":"crossref","DOI":"10.1080\/08897077.2018.1439797","article-title":"Retention of student pharmacists' knowledge and skills regarding overdose management with naloxone [published online ahead of print 4 April 2018]","author":"Jacobson","year":"2018","journal-title":"Subst Abus"}],"container-title":["Currents in Pharmacy Teaching and Learning"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877129718300133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877129718300133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:24:48Z","timestamp":1761798288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877129718300133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1877129718300133"],"URL":"https:\/\/doi.org\/10.1016\/j.cptl.2018.11.007","relation":{},"ISSN":["1877-1297"],"issn-type":[{"value":"1877-1297","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid overdose response training in pharmacy education: An analysis of students\u2019 perception of naloxone use for opioid overdose prevention","name":"articletitle","label":"Article Title"},{"value":"Currents in Pharmacy Teaching and Learning","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cptl.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}